Compounds and compositions as protein kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/04 (2006.01)

Patent

CA 2540518

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, PDGF-R, lck, SAPK2.alpha., p38, TGF.beta., KDR, c-Kit, b- RAF, c-RAF, FLT1 and FLT4 kinases.

L'invention porte sur une nouvelle classe de composés, sur des compositions pharmaceutiques comprenant ces composés et sur leurs procédés d'utilisation dans le traitement ou la prévention de maladies ou troubles associés à une activité anormale des kinases, notamment des maladies ou troubles impliquant l'activation anormale des kinases Abl, BCR-Abl, PDGF-R, lck, SAPK2?, p38, TGF?, KDR, c-Kit, b-RAF, c-RAF, FLT1 et FLT4.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds and compositions as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and compositions as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1785250

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.